Rothschild & CO Asset Management Us Inc. Gilead Sciences, Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $47 Million - $54.6 Million	-649,606 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $1.86 Million - $2.38 Million	-29,721 Reduced 4.38%	649,606 $48.6 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $1.14 Million - $1.25 Million	-18,420 Reduced 2.64%	679,327 $44.1 Million
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $901,081 - $994,635	-14,415 Reduced 2.02%	697,747 $44.2 Million
Q2 2019 Jul 25, 2019	SELL	$61.87 - $69.38 $3.21 Million - $3.6 Million	-51,920 Reduced 6.8%	712,162 $48.1 Million
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $53,525 - $59,962	-856 Reduced 0.11%	764,082 $49.7 Million
Q4 2018 Feb 05, 2019	SELL	$60.54 - $79.0 $1.33 Million - $1.73 Million	-21,912 Reduced 2.78%	764,938 $47.8 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $1.03 Million - $1.14 Million	14,412 Added 1.87%	786,850 $60.8 Million
Q2 2018 Aug 07, 2018	BUY	$64.88 - $75.68 $61,376 - $71,593	946 Added 0.12%	772,438 $54.7 Million
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $2.74 Million - $3.34 Million	-37,588 Reduced 4.65%	771,492 $58.2 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $2.21 Million - $2.6 Million	-31,075 Reduced 3.7%	809,080 $58 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $60.6 Million - $71.8 Million	840,155	840,155 $68.1 Million

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.